Who Paid My Doc
Vaxelis
Biological Vaccines
NDC 63361-243-15
General payments
$788,360
Research payments
$27,064
Through program year 2025, $788,360 in general payments and $27,064 in research payments were reported against Vaxelis (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $54,753 | 2,429 |
| 2024 | General | $114,402 | 5,162 |
| 2023 | General | $242,200 | 11,471 |
| 2022 | General | $227,881 | 11,543 |
| 2022 | Research | $27,064 | 10 |
| 2021 | General | $149,124 | 8,467 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 55 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
39,072 general · 10 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.